Unknown

Dataset Information

0

Value-Based Pricing of US Prescription Drugs: Estimated Savings Using Reports From the Institute for Clinical and Economic Review.

ABSTRACT:

SUBMITTER: Yeung K 

PROVIDER: S-EPMC9856524 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Value-Based Pricing of US Prescription Drugs: Estimated Savings Using Reports From the Institute for Clinical and Economic Review.

Yeung Kai K   Bloudek Lisa L   Ding Yao Y   Sullivan Sean D SD  

JAMA health forum 20221202 12

Similar Datasets

Unknown Estimated Savings From International Reference Pricing for Prescription Drugs.
| S-EPMC8433913 | biostudies-literature
Unknown Estimated Savings Under the Medicare High-Value Drug List Model.
| S-EPMC11420815 | biostudies-literature
Unknown Pricing, price revision, and clinical value of anticancer drugs in Japan: a retrospective observational study.
| S-EPMC12668999 | biostudies-literature
Unknown Estimated Savings From the Medicare Shared Savings Program.
| S-EPMC10724775 | biostudies-literature
Unknown Potential savings from an evidence-based consumer-oriented public education campaign on prescription drugs.
| S-EPMC2653882 | biostudies-literature
Unknown The value of innovation under value-based pricing.
| S-EPMC4826462 | biostudies-literature
Unknown Assays for estimating HIV incidence: updated global market assessment and estimated economic value.
| S-EPMC5810336 | biostudies-literature
Unknown Economic Evaluations in National Cancer Institute-Sponsored Network Cancer Clinical Trials.
| S-EPMC8262264 | biostudies-literature
Unknown Estimated Cost Savings: Everyone With Diabetes Counts (EDC) Program.
| S-EPMC5965937 | biostudies-literature
Unknown Optimal savings and the value of population.
| S-EPMC2141792 | biostudies-literature